NASDAQ:LVACW LAVA Medtech Acquisition (LVACW) Stock Price, News & Analysis → “Retirement Secret” Showed 995% Gain Last Time We Shared It (From Stansberry Research) (Ad) Free LVACW Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$0.01▼$0.0850-Day Range$0.00▼$0.1052-Week Range$0.00▼$0.29Volume4,700 shsAverage Volume6,639 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get LAVA Medtech Acquisition alerts: Email Address Ad Stansberry Research“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.Find out why right here (and see what you can do to get in too with just a few dollars). About LAVA Medtech Acquisition Stock (NASDAQ:LVACW)LAVA Medtech Acquisition Corp. intends to acquire assets and businesses through a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization. It focuses on pursuing opportunities in healthcare and healthcare-related industries primarily in the United States and Canada. The company was incorporated in 2021 and is based in Waltham, Massachusetts. LAVA Medtech Acquisition Corp. operates as a subsidiary of LAVA Medtech Sponsor LP.Read More Ad Stansberry Research“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.Find out why right here (and see what you can do to get in too with just a few dollars). LVACW Stock News HeadlinesAugust 11, 2023 | money.usnews.comMedTech Acquisition Corp - Ordinary Shares - Class AMay 2, 2023 | marketwatch.com8-K: LAVA Medtech Acquisition Corp.April 26, 2024 | Stansberry Research (Ad)“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.April 28, 2023 | finance.yahoo.comLAVA Medtech Acquisition Corp. Announces LiquidationFebruary 26, 2023 | msn.comVulcan Forged $LAVA Migrates to Elysium - Everything You Need to KnowSeptember 30, 2022 | finance.yahoo.comLAVA Medtech Acquisition Corp. (LVAC)September 9, 2022 | yahoo.comGutta-Percha Market to Reach $385.8 Million, Globally, by 2031 at 7.1% CAGR: Allied Market ResearchAugust 30, 2022 | finance.yahoo.comHow Many LAVA Medtech Acquisition Corp. (NASDAQ:LVAC) Shares Do Institutions Own?See More Headlines Receive LVACW Stock News and Ratings via Email Sign-up to receive the latest news and ratings for LAVA Medtech Acquisition and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeNASDAQ SectorFinance Industry Shell Companies Sub-IndustryN/A Current SymbolNASDAQ:LVACW CUSIPN/A CIK1855450 WebN/A Phone781-530-3868FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesDr. Anthony Natale M.B.A. (Age 48)M.D., CEO & Director Mr. Gerald A. Brunk M.B.A.Pres & DirectorMr. Vasco Larcina C.A.CPA, CPA, Chief Financial OfficerDr. Jean Daniel Hétu M.B.A.M.D., MBA, Exec. VPKey CompetitorsOmniLit AcquisitionNASDAQ:OLITWPerception Capital Corp. IINASDAQ:PCCTWVahanna Tech Edge Acquisition INASDAQ:VHNAWabrdn National Municipal Income FundNYSE:VFLAllianceBernstein Global High Income FundNYSE:AWFView All Competitors This page (NASDAQ:LVACW) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LAVA Medtech Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
